Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 53 clinical trials
Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia

Background Diseases related to human papillomavirus (HPV) include warts, lesions, and cancers. ICL is idiopathic CD4 T cell lymphocytopenia. People with this rare disease get more HPV-related diseases than other people do. The diseases are more severe and harder to treat in people with ICL. Researchers want to see if …

Accepts healthy volunteers
  • 131 views
  • 04 Oct, 2022
  • 1 location
Hashtag HPV: HPV Vaccine Twitter Education Program

cancer control and prevention efforts, including about the human papillomavirus (HPV) vaccine. A next step in this area of research is to develop and share messages on social media with parents to help

Accepts healthy volunteers
  • 0 views
  • 22 Mar, 2022
  • 1 location
A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

A total of 13500 Chinese women aged 18-45 years old were divided into three age groups: 18-26 years old, 27-35 years old, and 35-45 years old. The experimental group and the placebo group were randomly assigned in a ratio of 1:1. All subjects enrolled in the upper arm deltoid muscle …

Accepts healthy volunteers
  • 0 views
  • 15 Jun, 2022
  • 2 locations
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

The Main purpose of this study is to evaluate the safety and reactogenicity of GlaxoSmithKline Biologicals SA (GSK)'s investigational adjuvanted human papillomavirus (HPV) vaccine formulations

hpv vaccine
Accepts healthy volunteers
human papillomavirus
gardasil
  • 0 views
  • 07 Oct, 2022
  • 1 location
The HPV 9-10 Trial: Early Initiation of HPV Vaccination

Every year, thousands of Americans die from cancers related to human papillomavirus (HPV). The vast majority of those deaths could be prevented with a safe and effective vaccine, yet many parents choose not have their children vaccinated when it is recommended at age 11 or 12. In this study, we …

  • 0 views
  • 09 Jul, 2022
  • 1 location
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini

This is a multi-site, open-label non-inferiority study of the 9vHPV vaccine among a population of children, adolescents and young women living with HIV in Eswatini. This protocol seeks to assess immunogenicity of a two-dose 9vHPV vaccine regimen among girls and boys (9-14 years) and young women (15-26 years) living with …

  • 0 views
  • 26 May, 2022
  • 2 locations
Promoting HPV Vaccination Among Young Adults in Texas

The study uses a randomized controlled trial (RCT) to test an innovative multilevel intervention to increase HPV vaccination rates among young adults. The two primary outcomes will be the rate of HPV vaccination initiation by 3-month follow-up and rate of HPV vaccination completion by 9-month follow-up.

Accepts healthy volunteers
  • 26 views
  • 04 Oct, 2022
  • 1 location
HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV (COVENANT)

This randomized phase III trial studies how well human papillomavirus (HPV) vaccine therapy works in reducing high-grade cervical lesions in patients with human immunodeficiency virus (HIV) and

immunodeficiency
antiretroviral
HIV Vaccine
hiv-1 rna measurement
antiretroviral therapy
  • 77 views
  • 04 Oct, 2022
  • 4 locations
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy, Immunogenicity, and Safety of V503, a 9-Valent Human Papillomavirus (HPV) Vaccine, in Chinese Males 20 to 45 Years of Age

This study will evaluate the efficacy, immunogenicity, and safety of 9-valent human papillomavirus (9vHPV; V503) vaccine in Chinese men 20 to 45 years of age. It will enroll heterosexual men (HM) and men who have sex with men (MSM), will be stratified by age and sexual orientation, and will have …

Accepts healthy volunteers
  • 0 views
  • 11 Oct, 2022
  • 32 locations
I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination (IVaccinate)

This trial studies how well a multi-level health system-based intervention works in improving human papillomavirus (HPV) vaccine initiation and completion among children in health systems in

cancer
hpv vaccine
Accepts healthy volunteers
human papillomavirus
human papilloma virus vaccine
  • 0 views
  • 04 May, 2022
  • 3 locations